David B. Agus

Prostate Cancer Center|Cedars-Sinai Medical Center

Show Academic Trajectory

Ego Network

D-Core

Research Interests

Author Statistics

Experience

Education

Bio

None

Papers108 papers

Sort

By YearBy Citation

Abstract 5339: Paradoxical androgen receptor regulation by small molecule enantiomers

Katherin Patsch, Chao Liu,Boris Kashemirov, Harish Sura, Grzegorz Zapotoczny, Yuanye Sun, Pavan P. Shah,Jonathan E. Katz, Sujatha Chilakala, Ah Young Joo, Nolan Ung, Maya Aljehani

Cancer Research, (2020): 5339-5339

Bibtex

Deep learning-enabled breast cancer hormonal receptor status determination from base-level H&E stains

Nikhil Naik, Ali Madani, Andre Esteva, Nitish Shirish Keskar,Michael F Press,Daniel Ruderman,David B Agus,Richard Socher

Nature communications, no. 1 (2020): 5727-5727

WOSBibtex

Deep learned tissue "fingerprints" classify breast cancers by ER/PR/Her2 status from H&E images

Rishi R Rawat, Itzel Ortega, Preeyam Roy, Fei Sha, Darryl Shibata,Daniel Ruderman,David B Agus

Scientific reports, no. 1 (2020): 7275

WOSBibtex

Phase 2 trial of monoamine oxidase inhibitor phenelzine in biochemical recurrent prostate cancer

Mitchell E Gross,David B Agus,Tanya B Dorff,Jacek K Pinski,David I Quinn,Olga Castellanos, Patrick Gilmore,Jean C Shih

Prostate cancer and prostatic diseases, (2020): 94-94

WOSBibtex

Deep learning tissue "fingerprints" to identify patients and predict clinical subtypes of breast cancer from digital pathology images

Rishi Rawat,Fei Sha,Darryl Shibata,Daniel Ruderman,David Agus

CANCER RESEARCH, no. SUP13 (2019)

Bibtex

Monitoring dynamic cytotoxic chemotherapy response in castration-resistant prostate cancer using plasma cell-free DNA (cfDNA)

Katherin Patsch, Naim Matasci, Anjana Soundararajan, Patricia Diaz,David B Agus,Daniel Ruderman,Mitchell E Gross

BMC Research Notes, no. 1 (2019): 1-7

WOSBibtex

Abstract 2414: Interrogating cellular metabolism reveals mTORC2 as a new biomarker to stratify epidermal growth factor receptor-mutant non-small cell lung cancer

Chun-Te Chiang, Nolan Ung, Alexandra N. Demetriou, Chi-Li Chiu, Niha Choudhury, Cosimo Arnesano,Scott E. Fraser,David B. Agus, Naim Matasci, Dan L. Ruderman,Shannon M. Mumenthaler

CANCER RESEARCH, no. SUP13 (2018): 2414-2414

Bibtex

Toward high throughput immune infiltrate analysis from H&E stained images

Rishi R. Rawat,Daniel Ruderman,David B. Agus

CANCER RESEARCH, no. SUP13 (2018)

Bibtex

Abstract 5295: Toward high throughput immune infiltrate analysis from H&E stained images

Rishi Rawat,Daniel Ruderman,David B. Agus

Cancer Research, (2018): 5295-5295

Bibtex

Correlating nuclear morphometric patterns with estrogen receptor status in breast cancer pathologic specimens

Rishi R Rawat,Daniel Ruderman,Paul Macklin,David L Rimm,David B Agus

NPJ breast cancer, no. 1 (2018): 32

WOSBibtex

Safety and efficacy of everolimus (E), bevacizumab (B), and docetaxel (D) for castration resistant prostate cancer (CRPC)

Mitchell E. Gross,Tanya B. Dorff,David I. Quinn,Kristy Massopust, Patricia M Diaz,Olga O. Castellanos,David B. Agus

Journal of Clinical Oncology, (2017)

Cited by1Bibtex

Abstract 540: Deep learning to determine breast cancer estrogen receptor status from nuclear morphometric features in H&E images

Rishi Rawat,Daniel Ruderman,David B. Agus, Paul Macklin

Cancer Research, (2017): 540-540

Cited by1Bibtex

Abstract 3934: Bladder cancer tumor heterogeneity: development of a system-level mutation assay

Katherin Patsch, Naim Matasci, Anjana Soundararajan, John Nicoll,Jonathan E. Katz, Antonio Sanchez, Erika Feierstein, Christina Van Loy, Zhao Xu,David B. Agus,Mitchell E. Gross,Daniel Ruderman

Cancer Research, (2017): 3934-3934

Bibtex

Abstract 3731: A novel multidimensional cfDNA assay for real time analysis of chemotherapy response